Get started
Author

Marcella Palombarini

Observed name: M. Palombarini
ORCID: 0000-0002-4658-5345
Observed ORCID: 0000-0002-4658-5345
OpenAlex ID: A5044247632
Relationships between bladder dose–volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer
2014 · Viviana Carillo, Cesare Cozzarini, et al. · Radiotherapy and Oncology · 51
Stereotactic Radiotherapy in the Treatment of Lung Metastases from Bone and Soft-tissue Sarcomas.
2015 · Rezarta Frakulli, Fabrizio Salvi, et al. · PubMed · 43
Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer
2012 · Marcella Palombarini, Stefano Mengoli, et al. · Radiation Oncology · 35
PDF
Multi-variable models of large International Prostate Symptom Score worsening at the end of therapy in prostate cancer radiotherapy
2016 · Federica Palorini, Tiziana Rancati, et al. · Radiotherapy and Oncology · 27
Radiological differential diagnosis between fibrosis and recurrence after stereotactic body radiation therapy (SBRT) in early stage non-small cell lung cancer (NSCLC)
2017 · Rezarta Frakulli, Fabrizio Salvi, et al. · Translational Lung Cancer Research · 20
PDF
Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial
2026 · Michael D Jenkinson, Anna Rosala-Hallas, et al. · The Lancet · 4
PDF
Analysis of 1H-NMR relaxation time distributions in L1 to L6 rat lumbar vertebrae
2004 · P Fantazzini, C. Garavaglia, et al. · Magnetic Resonance Imaging · 4
Inhomogeneity of rat vertebrae trabecular architecture by high‐field 3D μ‐magnetic resonance imaging and variable threshold image segmentation
2009 · Marcella Palombarini, Mirko Gombia, et al. · Journal of Magnetic Resonance Imaging · 3
PV-0320: NTCP models of late severe urinary symptoms after radical IMRT for prostate cancer
2018 · F. Palorini, A. Cicchetti, et al. · Radiotherapy and Oncology · 2
PDF
595 poster COMPARISON OF DIFFERENT METHODS FOR OUTPUT FACTOR MEASUREMENTS ON 10 MEV LIAC LINACS
2011 · R. Romagnoli, S. Magi, et al. · Radiotherapy and Oncology · 2
41: Modelling acute urinary toxicity after radiotherapy for prostate cancer
2014 · V. Carillo, A. Botti, et al. · Radiotherapy and Oncology · 1
2159 Dose–response for late urinary incontinence after prostate cancer radiotherapy integrating α/β estimates, bladder volume effects, and patient factors
2026 · Gianluca Villa, Tiziana Rancati, et al. · Radiotherapy and Oncology
1647 SBRT for Solitary Pulmonary Nodule (SPN) with or without histological confirmation: long-term outcomes of a mono-institutional experience.
2025 · Francesca Di Pressa, Barbara Diletto, et al. · Radiotherapy and Oncology
Pp04.09 Dose-response Relationships for Late Patient-reported Urinary Side-efects After Prostate Cancer Radiotherapy. Maximum Likelihood Fit From Prospectively Collected Data
2024 · T. Rancati, F. Fiorino, et al. · Physica Medica
Mini-hta Report on Cyberknife Technology: Experience and Outcomes
2023 · M. Palombarini, S. Magi, et al. · Physica Medica
47. Dependence from dose and fractionation of late severe urinary toxicities after radical radiotherapy for prostate cancer
2018 · F. Palorini, A. Cicchetti, et al. · Physica Medica
Radiological differential diagnosis between fibrosis and recurrence after SBRT in early stage NSCLC
2017 · R. Frakulli, F. Salvi, et al. · European Journal of Cancer
EP-1216: Differential diagnosis between toxicity and recurrence after SBRT in early stage inoperable NSCLC
2016 · R. Frakulli, F. Salvi, et al. · Radiotherapy and Oncology
PDF
PO-0875: Multivariable models for urinary symptoms at 6-24 months after radical RT of prostate cancer
2016 · F. Palorini, T. Rancati, et al. · Radiotherapy and Oncology
Clinical and dose predictors for the incidence of late urinary symptoms after radical radiotherapy for prostate cancer
2016 · F. Palorini, T. Rancati, et al. · Physica Medica
Commissioning of volumetric modulated ARC therapy and patient QA with Octavius 2D Array and Gafchromic EBT3 films
2016 · M. Palombarini, R. Romagnoli, et al. · Physica Medica
3417 Stereotactic radiotherapy in the treatment of lung metastases from bone and soft tissue sarcomas: Final results
2015 · F. Salvi, R. Frakulli, et al. · European Journal of Cancer
EP-1170 Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer: retrospective observational study
2015 · M. Pieri, S. Cima, et al. · Radiotherapy and Oncology
PDF
EP-1583: Commissioning of volumetric modulated arc theraphy and patient QA with Octavius 2DArray and Gafchromic EBT3 films
2015 · M. Palombarini, S. Magi, et al. · Radiotherapy and Oncology
OC-0255: Multi-variable models of acute urinary toxicity: final results of a large prospective study
2015 · F. Palorini, T. Rancati, et al. · Radiotherapy and Oncology
PDF
Works count: 38
Citation count: 192
H-index: 5
I10-index: 5
Year
Topic
Type